Clomicalm

RSS

Clomipramine

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR) for Clomicalm. It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use Clomicalm.

For practical information about using Clomicalm, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.

This EPAR was last updated on 25/10/2021

Authorisation details

Product details
Name
Clomicalm
Agency product number
EMEA/V/C/000039
Active substance
clomipramine hydrochloride
International non-proprietary name (INN) or common name
Clomipramine
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QN06AA04
Publication details
Marketing-authorisation holder
Virbac S.A.
Revision
18
Date of issue of marketing authorisation valid throughout the European Union
01/04/1998
Contact address

1ère Avenue 2065 M - L.I.D.
06516 Carros Cedex
France

Product information

21/10/2021 Clomicalm - EMEA/V/C/000039 - IAIN/0039

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.

 

Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Psychoanaleptics

Therapeutic indication

As an aid in the treatment of separation related disorders in dogs manifested by destruction and inappropriate elimination (defecation and urination) and only in combination with behavioural modification techniques.

Assessment history

How useful was this page?

Add your rating
Average
1 rating